https://www.selleckchem.com/pr....oducts/pirfenidone.h
9 years. Regular non-aspirin NSAID use was associated with lower breast cancer risk [HR = 0.63; 95% confidence interval (CI) = 0.46-0.85; P = 0.002] with trends of lower risk (highest tertiles of use vs. nonuse) for greater number of years used [HR = 0.55; 95% CI = 0.31-0.97; Ptrend = 0.003), days used per month (HR = 0.51; 95% CI = 0.33-0.80; Ptrend = 0.001) and lifetime number of doses taken (HR = 0.53; 95% CI = 0.31-0.89; Ptrend = 0.003). We conclude that nonaspirin NSAID use is associated with statistically significant lower bre
Like
Comment
Share
